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Abstract
Mushroom-forming fungi produce a wide array of toxic alkaloids. However, evolutionary analyses aimed at exploring the
evolution of muscarine, a toxin that stimulates the parasympathetic nervous system, and psilocybin, a hallucinogen, have
never been performed. The known taxonomic distribution of muscarine within the Inocybaceae is limited, based only on
assays of species from temperate regions of the northern hemisphere. Here, we present a review of muscarine and
psilocybin assays performed on species of Inocybaceae during the last fifty years. To supplement these results, we used
liquid chromatography–tandem mass spectrometry (LC–MS/MS) to determine whether muscarine was present in 30 new
samples of Inocybaceae, the majority of which have not been previously assayed or that originated from either the tropics
or temperate regions of the southern hemisphere. Our main objective is to test the hypothesis that the presence of
muscarine is a shared ancestral feature of the Inocybaceae. In addition, we also test whether species of Inocyabceae that
produce psilocybin are monophyletic. Our findings suggest otherwise. Muscarine has evolved independently on several
occasions, together with several losses. We also detect at least two independent transitions of muscarine-free lineages to
psilocybin-producing states. Although not ancestral for the family as a whole, muscarine is a shared derived trait for an
inclusive clade containing three of the seven major lineages of Inocybaceae (the Inocybe, Nothocybe, and Pseudosperma
clades), the common ancestor of which may have evolved ca. 60 million years ago. Thus, muscarine represents a conserved
trait followed by several recent losses. Transitions to psilocybin from muscarine-producing ancestors occurred more recently
between 10–20 million years ago after muscarine loss in two separate lineages. Statistical analyses firmly reject a single
origin of muscarine-producing taxa.
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Introduction
The alkaloid muscarine, an ammonium quaternary compound
that stimulates the parasympathetic nervous system of animals, is
found in clinically significant amounts in basidiomata (fruitbodies)
of several distantly related groups of mushroom-forming fungi
(Clitocybe sensu lato, Mycena, Omphalotus, Inocybe) [1,2]. Muscarine
binds to acetylcholine receptors and induces a characteristic suite
of symptoms that include profuse sweating, lacrimation, and
bradycardia. These symptoms are generally expressed quickly
within two hours after consumption. The toxin is particularly
widespread in basidiomata of species of Inocybe sampled from
North America and Europe [3–13].
Species of Inocybe may be mistaken for, or mixed with, other
desirable species for consumption, perhaps in part because
mushrooms that contain muscarine tend to fruit in urban
environments and therefore are more easily collected for the table
or grazed by young children [2]. A flush of I. patouillardii (now
known as I. erubescens) in Germany in June 1963 led to mass
poisonings in humans [14]. Dogs are particularly susceptible to
muscarine poisoning with some cases resulting in death [15,16].
Over a thirty-year period in the United States, four reported cases
of human poisonings and ten in dogs were confirmed due to
muscarine intoxication [17]. However, most mushroom intoxica-
tions in the United States fail to be ascribed to any particular
fungal species. Outside the United States, muscarine intoxication
cases continue to be documented, including a recent human
fatality [18–20]. Fortunately, poisonings are rarely lethal in
humans, and atropine may be administered to patients to block
muscarine stimulation [2,21,22].
Psilocybin, a tryptamine alkaloid that acts on serotonin 5-HT2A/
C receptor sites and induces hallucinations [23], was first
demonstrated in Inocybe in the 1980s [3,24,25]. Several related
psychotropic toxins–norbaeocystin, baeocystin and psilocin–tend
to co-occur with psilocybin. A fifth, aeruginascin, an indole
alkaloid and trimethylammonium analogue of psilocybin, was
recently discovered in the European species I. aeruginascens [26].
This species has also been shown to lack muscarine [27]. Overall,
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six species of Inocybe, five of which correspond to section Lactiferae,
produce psilocybin and have been shown to lack muscarine (I.
coelestium, I. corydalina, I. erinaceomorpha, I. haemacta, and I. tricolor).
However, the classification of I. aeruginascens within subgenus
Inocybe is not known. Species of section Cervicolores (viz, I. calamistrata
and allies) lack muscarine as well but do not produce psilocybin or
other hallucinogenic compounds [3].
Although muscarine has been known as a toxin in Inocybe for
nearly 90 years, methods used for its detection have varied
widely. In 1920 muscarine was reported as the main toxin in I.
rimosa using physiological tests on the heart of a frog [28].
Later, muscarine was isolated as a tetrachloraurate salt from I.
patouillardii [29], and then again later from I. fastigata and I.
umbrina [30]. A paper chromatographic method was used in the
early 1960s [5] to determine muscarine concentrations in
various species of Inocybe. About the same time rat lacrimation
bioassays were also explored [9]. Later, chemotaxonomic tests
were employed to assay the presence of muscarine in selected
species of Inocybe [11]. During the 1980s and 1990s significant
advances were made that discovered stereoisomers of muscarine
and the presence of psilocybin and other psychotropic
compounds in species of Inocybe that lacked muscarine
[3,4,7,12,13,24,25,27,31]. These differences in detection meth-
ods produced some conflicting information about presence/
absence of muscarine in various species of Inocybaceae.
Few studies, mostly of the genus Inocybe, have examined the
distribution of muscarine within a systematic framework to
determine the evolutionary significance of the toxin [5,6].
Previously, it was hypothesized that the presence of muscarine
had little taxonomic correlation [5]. However, these authors
suggested the presence of muscarine may not be entirely random
taxonomically [13]. Unfortunately, these studies were hindered by
lack of robust phylogenetic hypotheses against which to map the
distribution of muscarine-containing species. At present, the
evolution of the toxin in the Inocybaceae is ambiguous, but if
ancestral would serve as a synapomorphy for the family, which
would further warrant separation from the Crepidotaceae [32],
the sister group of the Inocybaceae.
Kuyper [33] suggested that muscarine had multiple origins
and/or multiple losses within the genus Inocybe, but this
hypothesis has never been explicitly tested. Thus, it is unclear
during the course of evolution of the family where, and when,
any origins or losses occurred. Unfortunately, no species from
the tropics and southern hemisphere, including species of
Auritella and Tubariomyces, two recently described genera in the
family, have been assayed for the presence of muscarine and
psilocybin.
Here we present a literature review of species of Inocybaceae
reported to contain muscarine or psilocybin (the first since 1990
[34]), conduct LC–MS/MS analysis for muscarine presence in
30 species of Inocybaceae sampled primarily outside Europe,
and test the hypothesis that possession of muscarine is an
ancestral trait of the Inocybaceae. We also examine the number
of times psilocybin evolved in the family. To accomplish these
objectives, we assembled a dataset of nuclear large subunit
ribosomal RNA (LSU) sequences for ca. 500 species of Inocybe,
Auritella, and Tubariomyces, the most taxonomically inclusive
dataset for the family to date (ca. 500–700 species have been
estimated world-wide). We then reconstructed a chronogram for
the family to examine patterns of muscarine and psilocybin
evolution within a geological timeframe and test hypotheses for
single origins of muscarine and psilocybin within a statistical
framework.
Materials and Methods
Muscarine- and Psilocybin-containing Taxon Datasets
A literature review of muscarine and psilocybin reports in the
Inocybaceae was performed (Table S1). To this we added
muscarine presence-absence data for 30 new collections (Table 1)
including representatives from previously unsampled regions of
Asia, Australia, New Zealand, Africa, and the neotropics. Data
matrices for presence/absence of muscarine and psilocybin were
then compiled for taxa present in our phylogenetic data set (Table
S2) in Mesquite 2.73 [35].
Taxa from the phylogenetic data set were scored for muscarine-
psilocybin presence/absence (1/0 data) according to geographic
proximity of assayed species, where sequence data were lacking
from assayed collections. We employed this strategy to take into
account taxonomic uncertainties, whereby taxa were scored as
ambiguous. For example, Stijve et al. [13] reported presence of
muscarine in a European sample of I. flocculosa; our molecular data
set contains a sequence of I. flocculosa from Norway, so this tip was
scored as positive (1) for muscarine. However, Gurevich et al. [7]
report the presence of muscarine in Eurasian I. umbratica. We
scored the presence of muscarine as positive (1) in our European
sample of I. umbratica but scored our North American sample as
ambiguous because we lack muscarine data for North American
materials of this species or species group. In another example, both
Malone et al. [9] and Robbers et al. [11] report the presence of
muscarine in I. cinnamomea, a species endemic to the Pacific
Northwest. Our phylogenetic dataset contains a sequence from
material of I. cinnamonea collected in the Pacific Northwest, the
sequence of which is identical to that of the holotype from
northern California. Thus, this tip was scored as (1). In yet another
example, Western North American and European collections of I.
calamistrata are reported to lack muscarine [3,11,13]. Thus, tips
produced from collections sequenced from these geographic
regions were scored as (0); however, phylogenetically and
geographically distinct lineages of the I. calamistrata group (e.g., I.
aff. calamistrata from Costa Rica; I. mutata from eastern North
America; I. apiosmota from eastern North America) were scored as
ambiguous for the presence of both toxins. Because the presence of
both muscarine and psilocybin in species of Inocybaceae is
mutually exclusive [33], taxa confirmed as muscarine-positive
were coded psilocybin-negative, and psilocybin-positive taxa were
coded as muscarine-negative. To resolve any discrepancies in the
literature, we used a simple-majority approach or relied on
additional reports. For example, Gartz [36] suggests the presence
of psilocybin in I. calamistrata. However, both Besl and Mack [3]
and Stijve et al. [13] report its absence; thus, European tips of I.
calamistrata were scored as (0) for psilocybin based on simple-
majority rule. Futhermore, it has been suggested by Stijve &
Kuyper [37] that the technique used by Gartz [36] is prone to
false-positives, hence, further justification for coding European I.
calamistrata as psilocybin-negative.
Muscarine Chemical Analysis
Samples of basidiomata from 30 samples of Inocybaceae were
flash frozen in liquid nitrogen and then finely ground with a
mortar and pestle. The powdered samples, ranging from 10–
37 mg, were placed into 1.5 mL microcentrifuge tubes, vortexed
for 1 min, and extracted with 300 mL 4:1 methanol:deionized
H2O at 278uC for 20 min. The resulting suspensions were
centrifuged (13,200 rpm, 16,100 rcf, 5 min) to remove particu-
lates, and a 2 mL portion of the resulting supernatants from each
sample was transferred to 200 mL of deionized H2O in a separate
300 mL screwcap autosampler vial for analysis by LC–MS/MS as
Evolution of Toxins in the Inocybaceae
PLOS ONE | www.plosone.org 2 May 2013 | Volume 8 | Issue 5 | e64646
described below. The list of taxa sampled for muscarine detection
is provided in Table 1.
A Thermo Electron Surveyor Autosampler Plus was used to
inject 10 mL of each sample onto a Phenomenex Gemini reverse
phase C18 column consisting of fully porous organo-silica with
ethane cross-linking, organosilane (5 mm pore size, 110 Å particle
size, 15062 mm column size). High performance liquid chroma-
tography (HPLC) was performed utilizing a quaternary Thermo
Electron Surveyor MS Pump Plus with a column temperature of
25uC and a flow rate of 150 mL/min. The eluent was then
introduced into a Thermo Electron TSQ Quantum Discovery
Max triple quadrupole MS for ion detection. The mobile phases
were HPLC grade water (solvent A) and HPLC grade acetonitrile
(ACN) (solvent B), and these were used to construct the following
18 min gradient elution profile: t) 0 min, 15% solvent A, 85%
solvent B; t) 2 min, 15% solvent A, 85% solvent B; t) 4 min, 95%
Table 1. Taxa sampled for LC-MS/MS muscarine assays, specimen-voucher information, geographic origin, weights of samples,













Auritella brunnescens Matheny & Bougher,
nom. prov.
PBM3173 (TENN065742) Australia: New South Wales 0.011 0.012 JQ313558
Auritella serpentinocystis Matheny,
Trappe & Bougher
PBM3188 (TENN063641) Australia: New South Wales 0.019 0.014 JQ313559
Inocybe aff. Fibrillosibrunnea
O.K. Mill. & R.N. Hilton
PBM3245 (TENN065741) Australia: Tasmania 0.019 0.017 HQ832456
I. aff. fraudans (Britzelm.) Sacc. MTS2276 (UC) USA: California 0.021 0.020 EU433887
(JFA11831)
I. appendiculata Kühner SAT-00-261-55 (WTU) USA: Washington 0.022 0.022 JN974946
I. caerulata Matheny, G. Gates & Bougher,
nom. prov.
PBM3127 (TENN063699) New Zealand 0.026 0.017 JQ313560
I. cf. graveolens (E. Horak) Garrido PBM3398 (TENN065746) Australia: Tasmania 0.021 0.018 JQ313561
I. chondroderma Stuntz ex Matheny,
Giles & Norvell
PBM2027 (WTU) USA: Washington 0.020 0018 JN974967
(PBM1776)
I. grammata Quél. & Le Bret. PBM2558 (TENN062401) USA: New Hampshire 0.031 0.023 JQ313562
I. granulosipes Cleland PBM3240 (TENN065744) Australia: Tasmania 0.029 0.016 JQ313563
I. granulosipes Cleland PBM3363 (TENN065747) Australia: Tasmania 0.017 0.016 2
I. lanatodisca Kauffman PBM2444 (TENN062505) USA: Massachusetts 0.027 0.037 JQ313564
I. leiocephala D.E. Stuntz PBM1569 (WTU) USA: Wyoming 0.018 0.032 GQ906703
I. luteifolia A.H. Sm. PBM2642 (TENN062473) USA: Tennessee 0.025 0.018 EU307814
I. marginata Matheny, Aime & T.W. Henkel MCA3190 (BRG) Guyana 0.010 0.017 JN642239
I. misakaensis Matheny & Watling BB3453 (PC0088768) Zambia 0.029 0.021 JQ313565
I. niveivelata Stuntz ex Kropp,
Matheny & Hutchinson
PBM2337 (WTU) USA: Washington 0.021 0.020 JQ313566
I. aff. perlata (Cooke) Sacc. JV4336 (WTU) Finland 0.024 0.021 JQ313567
I. pileosulcata E. Horak, Matheny
& Desjardin, nom. prov.
DED8058 (SFSU, ZT13025) Thailand 0.019 0.011 EU600838
I. rimosoides Peck PBM2459 (TENN062320) USA: New York 0.020 0.025 AY702014
I. scissa (E. Horak) Garrido PBM3394 (TENN065745) Australia: Tasmania 0.025 0.030 JQ313568
I. spuria Jacobsson & E. Larss. BK18089723 (UTC) USA: Utah 0.021 0.033 EU600868
I. subexilis Peck PBM2620 (TENN062456) USA: Tennessee 0.011 N/A EU307845
I. subochracea (Peck) Peck SH083007 (TENN065743) USA: New Jersey 0.031 0.030 JN974972
I. tahquamenonensis D.E. Stuntz PBM2680 (TENN062505) USA: New York 0.027 0.022 AY380399
(PBM1142)
I. unicolor Peck PBM2974 (TENN062732) USA: Tennessee 0.023 0.022 JQ313569
I. vinaceobrunnea Matheny, nom. prov.
( = I. jurana (Pat.) Sacc. sensu Hesler
PBM2951 (TENN062709) USA: Tennessee 0.030 0.036 HQ201353
I. viscata (E. Horak) Garrido PBM3445 (TENN065734) Australia: Tasmania 0.024 0.032 JQ313570




Heykoop & E. Horak) Esteve-Rav. & Matheny
AH25500 Spain 0.010 N/A GU907091
doi:10.1371/journal.pone.0064646.t001
Evolution of Toxins in the Inocybaceae
PLOS ONE | www.plosone.org 3 May 2013 | Volume 8 | Issue 5 | e64646
solvent A, 5% solvent B; t) 14, 95% solvent A, 5% solvent B; t) 16,
15% solvent A, 85% solvent B; t) 18, 15% solvent A, 85% solvent
B.
A 0.1 mm internal diameter fused silica capillary was used to
introduce samples into the electrospray ionization (ESI) chamber
of the triple quadrupole MS. The ESI spray voltage was set at
4500 V for positive ion mode detection. The sheath gas was
nitrogen (40 psi), and the inlet capillary temperature was 290uC.
The argon collision gas pressure was 1.5 mTorr. Muscarine was
detected using selected reaction monitoring (SRM) for the
following unique parent mass-to-charge (m/z)–product m/z
combinations at the listed collision energy (in eV): 174 m/z–
57 m/z, eV 19; 174 m/z–115 m/z, eV 16; 174 m/z–60 m/z, eV 19;
174 m/z–97 m/z, eV 17. The scan time for each SRM was 0.05 s
with a scan width of 0.1 m/z.
A 2.8 mM standard solution of muscarine was introduced into
the MS/MS via direct injection. The four muscarine parent m/z–
fragments m/z pairs that provided the best detection were then
determined using the automated MS+MS/MS optimization
algorithm provided in Quantum Tune of the Xcalibur v. 2.0.7
software package (Thermo Electron). Once optimized parameters
were obtained, the standard sample was introduced onto the
column and analyzed via LC2MS/MS using the previously
discussed methods. The muscarine standard eluted from the
column at a retention time of 1.8 min. Muscarine was scored as
present or absent by comparing sample chromatograms to the
muscarine standard.
DNA Extractions, PCR, and Sequencing
We extracted DNA from 24 of the 30 samples used in the
muscarine assays. From these we sequenced the LSU region using
primers LR0R, LR7, LR3R, LR5, and LR16. DNA extractions,
PCR, and sequencing were performed following procedures
described in detail by Matheny [32] and Judge [36]. These
sequences, or those from conspecific collections, were used for
phylogenetic analysis. All new sequences have been submitted to
GenBank, a data depository of the National Center for Biotech-
nology Information (NCBI).
Phylogenetic Analysis and Ancestral State
Reconstructions (ASR)
We assembled an alignment of 497 LSU sequences using
MacClade [38] to test the hypothesis that the presence of
muscarine is ancestral in the Inocybaceae. This alignment is
composed of LSU sequences produced primarily from studies
[32,39–45]. BEAST 1.6.1 [46] was used to generate a time
calibrated phylogenetic estimate. Five independent runs were
executed in BEAST using Markov chain Monte Carlo (MCMC)
sampling for 50 million generations, sampling trees and other
parameters every 5000 generations. A General-Time-Reversible
(GTR) model was used for nucleotide substitution rates in
combination with parameters that estimate the proportion of
invariable sites and gamma distributed rate heterogeneity to
account for substitution rate variation among nucleotide sites.
Model selection for molecular evolution was based on Matheny
et al. [39] and Ryberg & Matheny [44]. Based on a time
calibrated Basidiomycota dataset [47], a normal distributed age
prior with a mean of 94 My (million years) and a standard
deviation (SD) of 15 My was set for the root height (split between
Inocybaceae and the outgrop Cortinarius). In addition we applied a
normal distributed age prior with a mean value of 50.3 My (SD
12) for the split between Inocybaceae and its sister group, the
Crepidotaceae. A Yule model was used as a prior for the
distribution of node heights. Tracer 1.5 [46] and AWTY [48] were
used to evaluate if convergence had been reached and how many
generations to discard as the burn-in.
Parsimony ancestral state reconstruction (ASR) of muscarine
and psilocybin production was performed in Mesquite 2.73 [35].
An ASR analysis was performed for each tree in the posterior
distribution produced by BEAST. To evaluate whether the
distribution of the traits was significantly dependent on the
phylogeny, the traits were randomized between the tips (excluding
tips for which there were no data), and the parsimony score was
calculated in the R package phangorn [49]. One hundred
randomizations were performed for each tree in the posterior
distribution, and these were compared to the parsimony score for
the observed data [50,51].
Testing for Monophyly of Muscarine- and Psilocybin-
containing Inocybaceae
Two approaches were used to evaluate if muscarine and
psilocybin, respectively, are restricted to monophyletic groups.
The first approach compared the maximum likelihood of trees
constrained to be monophyletic for muscarine and psilocybin,
respectively, with the maximum likelihood of the unconstrained
tree. Taxa for which the toxin presence was unknown were left
unconstrained in all analyses. The maximum likelihood analyses
were performed under the GTR plus gamma and invariable sites
model, and the tree topologies were compared using the
Shimodaira-Hasegawa test (SH-test) [52] in RAxML 7.2.8 [53].
The second approach compared hypotheses of monophyly of
muscarine and psilocybin-containing species, respectively, with
non-monophyletic alternatives using posterior probabilites. This
was done using the APE [54] package in R [54] analyzing the
combined post burn-in posterior distributions from the BEAST
analyses. Taxa for which muscarine and psilocybin presence were
unknown were excluded from each tree in the posterior
distribution. The proportion of trees with the group as monophy-
letic was compared to the proportion of trees where it was not.
Results
LC2MS/MS Muscarine Assays
Of the 30 species we assayed, eleven species of Inocybe tested
positive for presence of muscarine (Fig. 1). Samples of I. niveivelata
and I. vinaceobrunnea nom. prov. ( = I. jurana sensu Hesler), however,
are likely clinically insignificant. Muscarine concentrations (nor-
malized) for each sample are shown. Concentrations of muscarine
are highest in the Australian-New Zealand species I. scissa. The
next highest concentrations were detected in I. aff. fibrillosibrunnea
and I. marginata, but these samples contained only about half the
concentration of muscarine as detected in I. scissa. Muscarine
detection results from samples of I. subexilis (negative), I. leiocephala
( = I. subbrunnea) (positive), and I. grammata ( = I. albodisca) (negative)
are consistent with earlier findings [5,6,11].
Synopsis of Muscarine- and Psilocybin-containing
Species of Inocybaceae
Based on a literature review and the addition of 30 samples
here, 99 species of Inocybaceae (96 Inocybe, two Auritella, one
Tubariomyces) have been assayed for the presence of muscarine after
excluding taxonomic redundancies (Table S1). Of these 99 taxa,
68 (also excluding taxonomic redundancies) have been reported to
contain muscarine. Five species from Europe are reported to
contain psilocybin, and all lack muscarine.
Considering their phylogenetic placement, six species of
subgenus Mallocybe (Mallocybe clade) have been assayed. Of these,
I. agardhii, I. dulcamara, I. caesariata [55], and I. malenconii have been
Evolution of Toxins in the Inocybaceae
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reported as muscarine positive. However, I. terrigena and I. unicolor
lack muscarine. Within section Rimosae s. str. (Pseudosperma
clade), five species have been assayed. Of these, I. rimosa, I.
niveivelata, I. sororia, and I. spuria are muscarine positive. Only I.
perlata is reported to lack muscarine. Twelve species of section
Cervicolores and the ‘maculata clade’ [43] (two major lineages of the
Inosperma clade) have been assayed and included in our
phylogenetic analysis. Of these, only three species are muscarine
positive: I. erubescens, I. maculata, and I. vinaceobrunnea nom. prov.
(the latter likely clinically insignificant). Inocybe adaequata, I.
bongardii, I. calamistrata, I. cervicolor, I. cookei, I. hirsuta var. maxima,
I. lanatodisca, I. misakaensis, and I. rimosoides are nine species within
the Inosperma clade that lack muscarine. In subgenus Inocybe
(Inocybe clade) numerous species are reported as muscarine
positive. However, the following lack muscarine and psilocybin: I.
appendiculata, I. fraudans, I. aff. fraudans, I. godeyi, I. grammata ( = I.
albodisca), I. granulosipes, I. incarnata, I. luteifolia, I. nigrescens, I. subexilis,
I. tahquamenonsis, I. viscata, and I. xanthomelas. Species of Auritella and
Tubariomyces sampled here also lack muscarine.
The following species in Table S1 lack muscarine but possess
psilocybin: I. aeruginascens, I. coelestium, I. corydalina, I. haemacta, and I.
tricolor. All five psilocybin-containing species appear to be endemic
to Europe. One specimen from California reported as I. bohemica
nom. prov. represents a distinct North American species in the I.
corydalina group and features the typical blue-green discoloration
on the pileus and stipe of basidiomata as in European I. corydalina.
Given this taxon is nested within what is otherwise a European
group of hallucinogenic species, we scored it positive (1) for
psilocybin presence. Scoring this taxon as ambiguous for
psilocybin made no difference in the number of reconstructed
gains of the trait.
We did record several discrepancies of the presence or absence
of muscarine in the following species: I. albodisca, I. cervicolor, I.
curvipes, I. dulcamara, I. pelargonium, I. picrosma, I. praetervisa, I. serotina,
and I. xanthomelas (Table S1). Of these taxa, it seems reasonable
that muscarine is indeed lacking from I. albodisca, I. cervicolor, and I.
xanthomelas due to a majority or more recent studies that confirm
the absence of the toxin. Confusion over species recognition may
complicate evaluations of the presence or absence of muscarine in
the other taxa listed above. Multiple exemplars of these species
should be re-evaluated. One discrepancy was noted for the
presence of psilocybin in I. calamistrata [36], which has since been
demonstrated as psilocybin negative [37].
Previous reports sampled taxa exclusively from Europe or North
America. Two species of Auritella (A. brunnescens nom. prov. and A.
serpentinocystis), both from Australia, lack muscarine. Of four
tropical taxa sampled in this study, three produce muscarine (I.
marginata from Guyana, I. xerophytica from the Caribbean, and I.
pileosulcata nom. prov. from Thailand); the tropical species I.
misakaensis from Zambia lacks muscarine, but the absence of this
toxin is typical for species of section Cervicolores to which I.
misakaensis belongs. Of six temperate Australian and New Zealand
species, three (I. aff. fibrillosibrunnea, I. scissa, and I. cf. graveolens)
contain muscarine; three others (I. caerulata nom. prov., I.
granulosipes and I. viscata) do not. In addition, this is the first study
to assay a species of Tubariomyces [42] for presence of muscarine.
The type of this genus from mediterranean Spain (T. inexpectatus) is
confirmed to lack this alkaloid.
Muscarine is an Older Molecule than Psilocybin but Both
are Phylogenetically Conserved
The first 30 million generations of each of the five BEAST runs
were discarded as burn-in resulting in a final posterior tree
distribution of 20 000 trees. The topology of the tree is largely in
agreement with previous multigene analyses [32,44]. The
randomization test indicates that both muscarine and psilocybin
are significantly dependent on the phylogeny, that is, both are
phylogenetically conserved (average P,,0.001). Fig. 2 illustrates
the evolution of muscarine- and psilocybin-containing taxa based
on an ancestral state reconstruction analysis (Fig. S1 displays a
more detailed version of Fig. 2). Muscarine has evolved on
multiple occasions but appears to have first originated about 60
million years ago. Psilocybin is present in two independent lineages
with each transition occurring much more recently between 10–20
million years ago.
Polyphyly of Muscarine and Psilocybin-Containing Taxa
The SH-test demonstrates that the most likely tree in which
muscarine-containing species are enforced to be monophyletic is
significantly worse than the unconstrained tree (p,0.01). The most
likely tree with psilocybin-containing taxa enforced as monophy-
Figure 1. Relative muscarine concentrations measured by
liquid chromatography-tandem mass spectrometry. The con-
centration of muscarine for each sample was determined from the ion
counts measured using SRM 174 m/z–57 m/z. Biological duplicates
were used for extraction, and each sample was also injected in
duplicate. These four measurements were then averaged. Note: the
data reported above have been divided by 106 to minimize the display
magnitude of the x-axis units and better highlight the relative amounts
between samples. Two species (marked with an *) contained less than
1% of the muscarine concentration of the others. While this amount
may not be clinically relevant, the validity of the measurement was
confirmed using alternate SRMs.
doi:10.1371/journal.pone.0064646.g001
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letic is not significantly worse than the unconstrained tree
(p.0.05). Given the conserved nature of the SH-test [52], we
also filtered the proportion of trees in which psilocybin-containing
(and muscarine-containing) taxa were monophyletic. None of the
trees sampled in the posterior distribution were consistent with
these taxonomic constraints. Thus, the posterior odds strongly
reject the monophyly of groups containing muscarine or
psilocybin.
Discussion
Muscarine and psilocybin are two toxic-inducing secondary
metabolites found widely in distantly related lineages of Agaricales.
Muscarine induces a suite of symptoms (viz, excessive sweating,
lacrimation, and salivation) in response to stimulation of the
parasympathetic nervous system. Muscarine is found mainly in
species of Inocybaceae but does occur in clinically significant
amounts in other genera, including some species of Clitocybe sensu
lato, and Mycena [1,4]. Mushroom-forming fungi that contain
tryptamine derivates (viz, psilocybin) include species of Psilocybe,
Panaeolus, Conocybe, Inocybe, Gymnopilus, Lycodperdon, and Pluteus [2].
All seven of these genera are restricted to the Agaricales with all of
them, except for Pluteus, nested in the Agaricoid clade in Matheny
et al. (2006) [56]. The evolution of these toxins in mushroom-
forming fungi has yet to be evaluated, but we would predict each
Figure 2. Phylogeny of the Inocybaceae and ancestral state reconstruction of the evolution of muscarine and psilocybin; red
indicates the presence of muscarine, green indicates the presence of psilocybin, gray is ambiguous for muscarine, and black
indicates the lack of muscarine and lack of psilocybin. Circles indicate time intervals of 10 million years. Dots next to tips indicate species that
have been assayed for either muscarine or psilocybin. Major clades of Inocybaceae following [32] are labeled.
doi:10.1371/journal.pone.0064646.g002
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lineage has acquired either of the two toxins independently given
known phylogenetic relationships at this time.
Here, we have provided a comprehensive review of species of
Inocybaceae assayed for muscarine and psilocybin over the past 50
years, and to this review we add new data from assays of 30
collections, most of these originating outside Europe and North
America. Despite our sampling efforts, only ca. 19% (98 of 507
accepted species) of the family has been assayed for the toxin. This
percentage is likely to be lower given that the number of species of
Inocybaceae may approach 700 [32] and that novel species
continue to be described [42,57–60].
During the course of our review, we came across several
obstacles. One, comparing results from each study was challenging
because different methods were employed that could be expected
to provide varying levels of confidence in the reported relative
amounts of muscarine. In the 1960s, for example, a bioassay was
used that predicted greater amounts of muscarine than chemical
assays [9]. Two, we also observed several taxonomic quandaries: I.
flocculosa, for example, is reported under three different names in
the muscarine literature (I. flocculosa, I. lucifuga, and I. gausapata); all
three proved positive for muscarine. In addition, it is now known
the I. rimosa complex is composed of numerous phylogenetic
species [42]. As a consequence, we only coded as positive the most
reliably identified sample (from northern Europe) rendering five
other potentially unique species in the complex as ambiguous.
Three, we also observed that muscarine positive results were
supplied in different forms. Gurevich et al. [7], for example,
employed a +/2 system to record results, whereas Stijve [12] used
a % yield. As a conservative measure, we refined all of the data
into a +/2 system and resolved conflicting results by majority-
rule. Lastly, in the literature we uncovered a clear geographic bias
for taxa sampled from Europe and North America only.
Little taxonomic correlation has been claimed with respect to
the taxonomic distribution of muscarine-containing species of
Inocybaceae [5,6]. However, these prior studies lacked a robust
phylogenetic perspective to test the hypothesis. Others, however,
have suggested the distribution of muscarine may exhibit some
taxonomic correlation [13], a result corroborated here on two
grounds: (i) the presence of muscarine is ancestral for a large
inclusive clade containing three major lineages–Inocybe s. str.
( = subgenus Inocybe), the Pseudosperma clade ( = section Rimosae s.
str.), and the Nothocybe lineage (a single stem lineage containing an
ambiguously identified species from India); and (ii) a randomiza-
tion test indicates the taxonomic distribution of muscarine is
phylogenetically conserved, more so than expected by chance.
A chronogram of our LSU dataset, which includes approxi-
mately 500 species, suggests muscarine initially evolved about 60
million years ago but is not ancestral for the family. This result
does not support our null hypothesis. Ancestral state analyses
document between 10–13 losses of muscarine across the family,
but the presence of muscarine is a highly conserved trait for a
large, speciose, and inclusive clade including Inocybe s. str., the
Nothocybe lineage, and the Pseudosperma clade. While muscarine is
present in the most derived group of the Mallocybe clade and in
three species of the Inosperma clade, it was not detected in deeply
branching lineages of the Mallocybe clade and is absent from species
of Auritella and Tubariomyces among species sampled thus far.
The chronogram also informs us of a minimum of two
independent transitions to a psilocybin-containing state, both of
which occurred relatively recently during the Miocene between 10
and 20 million years ago, once in a lineage containing I. tricolor, I.
haemacta, and I. corydalina and its allies; and independently in I.
aeruginascens. All of these species are known only from Europe. We
speculate that nLSU-rRNA data alone, combined with the
conservative SH-test [52], lack the power to reject the alternative
hypothesis of the monophyly of psilocybin-containing taxa.
Nevertheless, these results reinforce the observation that the loss
of muscarine precedes evolutionary gains of psilocybin. Not all
muscarine-lacking taxa, however, produce psilocybin. Indeed,
psilocybin-containing taxa are quite rare in the family (app. 1% if
one accepts a conservative estimate of ca. 500 species).
Two caveats may temper our results. First, assays for these
toxins are hardly taxonomically complete. For example, only 19%
of species of Inocybaceae have been assayed for muscarine.
However, our phylogenetic results here should serve as a
springboard from which to target additional or crucial taxa.
Second, our results are dependent on a single gene phylogenetic
analysis. Despite this limitation, our LSU dataset is the most
taxonomically densely sampled phylogeny of the family to date.
We are now in a position to predict that species of Auritella,
Tubariomyces, and deeply branching species of the Mallocybe clade
and Inosperma clade lack muscarine altogether and that unknown
species nested in the I. corydalina group should possess psilocybin.
Areas of future research should focus on the mechanisms of
muscarine gain, loss, and expression, as well as potential selection
pressures on its maintenance or loss. Other groups besides the
Inocybaceae merit investigation and might be more amenable to
laboratory experiments (e.g., Omphalotus). It is also unclear if
muscarine is expressed in mycelia of these fungi; which organisms,
if any, are subject to biochemical deterrence; and the extent to
which muscarine acts as a biological defense compound.
Invertebrates, such as nematodes and insects, do possess musca-
rinic acetylcholine receptors [61,62] and thus may be prone to
muscarine intoxication.
Lastly, muscarine and psilocybin are both mutually exclusive
compounds in species of Inocybaceae. That is, both toxins have
not been found to co-occur in a single species. The biochemical
pathways that generate the two toxins are quite different and
unrelated [63,64,4]. Glutamic acid is a pre-cursor to muscarine,
whereas tryptophan is a pre-cursor to psilocybin. However, it
would appear the loss of muscarine is a prerequisite to a gain of
psilocybin in species of Inocybe. This observation is supported by
placement of one monophyletic group of psilocybing-containing
species (I. corydalina and closely related allies) within a grade of taxa
(I. fraudans and allies) lacking muscarine (Fig. 2). While a second
psilocybin-containing lineage of Inocybe (I. aeruginascens) evolved
independently, its sister lineage is not known with confidence.
Inocybe glabripes is indicated here as a possible sister lineage to I.
aeruginascens, but the toxic status of the former is unknown.
Additional research is required to address biochemical or
metabolic reasons for this pattern of mutual exclusivity.
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28. Fahrig C (1920) Über die Vergiftung durch Pilze aus der Gattung Inocybe
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